| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues: |
| Service - Software subscription and services | | | | 0.1 | | | | 0.1 |
| Service - Medication safety services | | | | 0.8 | | | | 2.8 |
| Shared Services and Other | | | 1.5 | 0.9 | | | 2.9 | 2.9 |
| Service - PACE solutions | | | | 16.4 | | | | 14.7 |
| Other | | | 81.2 | 58.9 | | | 66.0 | 47.4 |
| Total revenues | 90.0 | 88.3 | 82.7 | 77.1 | 72.6 | 67.1 | 68.9 | 67.9 |
| Revenue growth [+] | 24.0% | 31.5% | 20.0% | 13.5% | 12.9% | 14.2% | -10.6% | -3.7% |
| Service - Medication safety services | | | | -70.1% | | | | |
| Shared Services and Other | | | -48.8% | -68.6% | | | | |
| Service - PACE solutions | | | | 11.6% | | | | |
| CareVention HealthCare | | | 23.1% | 17.2% | | | 16.1% | 29.3% |
| Cost of goods sold | 67.5 | 67.5 | 63.0 | 60.2 | 56.6 | 52.7 | 50.6 | 51.2 |
| Gross profit | 22.5 | 20.8 | 19.7 | 16.9 | 16.0 | 14.4 | 18.3 | 16.7 |
| Gross margin | 25.0% | 23.5% | 23.8% | 21.9% | 22.0% | 21.4% | 26.6% | 24.6% |
| Selling, general and administrative [+] | 20.3 | 19.0 | 18.8 | 30.8 | 17.3 | 18.5 | 20.2 | 17.1 |
| Sales and marketing | 2.7 | 2.5 | 2.8 | 2.9 | 2.2 | 2.6 | 2.8 | 2.7 |
| General and administrative | 17.6 | 16.6 | 16.0 | 27.9 | 15.2 | 15.9 | 17.4 | 14.4 |
| Research and development | 1.8 | 1.3 | 3.3 | 4.0 | 3.2 | 4.0 | 3.6 | 3.7 |
| Other operating expenses | 3.4 | 0.4 | 3.7 | | | | | |
| Adjusted EBITDA | -0.2 | 2.5 | -1.8 | -0.7 | 2.1 | 7.8 | 11.1 | 10.7 |
| Adjusted EBITDA margin | -0.2% | 2.8% | -2.1% | -0.9% | 2.9% | 11.7% | 16.1% | 15.7% |
| Stock-based compensation | 2.8 | 2.5 | 4.3 | 17.2 | 6.7 | 8.6 | 9.5 | 8.0 |
| EBITDA [+] | -2.9 | 0.0 | -6.1 | -17.9 | -4.6 | -0.8 | 1.6 | 2.7 |
| EBITDA growth | -36.3% | -105.7% | -483.6% | -775.2% | 2372.6% | -184.2% | -153.0% | -140.9% |
| EBITDA margin | -3.3% | 0.0% | -7.3% | -23.3% | -6.3% | -1.2% | 2.3% | 3.9% |
| Depreciation | 4.5 | 4.6 | 4.4 | 4.0 | 3.8 | 11.4 | 10.5 | 10.2 |
| EBITA | -7.4 | -4.6 | -10.5 | -22.0 | -8.4 | -12.2 | -9.0 | -7.5 |
| EBITA margin | -8.3% | -5.2% | -12.7% | -28.5% | -11.6% | -18.1% | -13.0% | -11.1% |
| Amortization of intangibles | 1.6 | 1.6 | 1.9 | 1.7 | 1.7 | 1.7 | 1.8 | 1.9 |
| EBIT [+] | -9.0 | -6.2 | -12.5 | -23.6 | -10.1 | -13.8 | -10.8 | -9.4 |
| EBIT growth | -10.5% | -55.5% | 15.4% | 150.4% | -14.5% | 29.3% | -31.3% | -49.5% |
| EBIT margin | -10.0% | -7.0% | -15.1% | -30.7% | -13.9% | -20.6% | -15.7% | -13.9% |
| Non-recurring items [+] | | | 4.9 | | | 4.1 | | |
| Asset impairment | | | 4.9 | | | 4.1 | | |
| Interest expense | 1.1 | 1.3 | 1.6 | 2.7 | 2.4 | 2.3 | 2.1 | 2.2 |
| Interest expense | 1.1 | 1.3 | 1.6 | 2.7 | 2.4 | 2.3 | 2.1 | 2.2 |
| Other income (expense), net [+] | 0.6 | 0.5 | 0.6 | 0.5 | | | | |
| Other | 0.6 | 0.5 | 0.6 | 0.5 | | | | |
| Pre-tax income | -9.6 | -7.0 | -18.4 | -25.9 | -12.5 | -20.2 | -12.9 | -11.7 |
| Income taxes | 0.1 | 0.1 | 0.0 | 0.0 | 0.2 | 0.2 | 0.1 | 0.1 |
| Tax rate | | | | 0.0% | | | | |
| Earnings from continuing ops | -9.7 | -7.1 | -18.4 | -25.9 | -12.7 | -20.4 | -13.0 | -11.8 |
| Earnings from discontinued ops | | -8.8 | -11.3 | -14.2 | | -7.8 | -8.3 | -5.4 |
| Net income | -9.9 | -15.9 | -29.6 | -40.1 | -49.6 | -28.2 | -21.4 | -17.1 |
| Net margin | -10.9% | -18.0% | -35.8% | -52.0% | -68.3% | -42.0% | -31.0% | -25.2% |
| |
| Basic EPS [+] | ($0.38) | ($0.28) | ($0.76) | ($1.06) | ($0.53) | ($0.85) | ($0.56) | ($0.50) |
| Growth | -27.6% | -67.2% | 35.1% | 111.6% | -12.4% | 47.0% | -60.1% | -49.3% |
| Diluted EPS [+] | ($0.38) | ($0.28) | ($0.76) | ($1.06) | ($0.53) | ($0.85) | ($0.56) | ($0.50) |
| Growth | -27.6% | -67.2% | 35.1% | 111.6% | -12.4% | 47.0% | -60.1% | -49.3% |
| |
| Shares outstanding (basic) [+] | 25.4 | 25.2 | 24.3 | 24.4 | 24.0 | 23.9 | 23.3 | 23.4 |
| Growth | 6.1% | 5.8% | 4.3% | 4.0% | 3.0% | 3.7% | 6.8% | 7.5% |
| Shares outstanding (diluted) [+] | 25.4 | 25.2 | 24.3 | 24.4 | 24.0 | 23.9 | 23.3 | 23.4 |
| Growth | 6.1% | 5.8% | 4.3% | 4.0% | 3.0% | 3.7% | 6.8% | 7.5% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |